These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Hiraoka N; Onozato K; Kosuge T; Hirohashi S Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676 [TBL] [Abstract][Full Text] [Related]
24. Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection. Chen KJ; Zhou L; Xie HY; Ahmed TE; Feng XW; Zheng SS Med Oncol; 2012 Sep; 29(3):1817-26. PubMed ID: 21678026 [TBL] [Abstract][Full Text] [Related]
25. Tumor-Infiltrating Neutrophils Predict Poor Survival of Non-Functional Pancreatic Neuroendocrine Tumor. Zhang WH; Wang WQ; Gao HL; Xu SS; Li S; Li TJ; Han X; Xu HX; Li H; Jiang W; Ye LY; Lin X; Wu CT; Yu XJ; Liu L J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32285127 [TBL] [Abstract][Full Text] [Related]
26. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038 [TBL] [Abstract][Full Text] [Related]
27. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis. Masuda S; Yamakawa K; Masuda A; Toyama H; Sofue K; Nanno Y; Komatsu S; Omiya S; Sakai A; Kobayashi T; Tanaka T; Tsujimae M; Ashina S; Gonda M; Abe S; Uemura H; Kohashi S; Inomata N; Nagao K; Harada Y; Miki M; Irie Y; Juri N; Kanzawa M; Itoh T; Fukumoto T; Kodama Y Ann Surg Oncol; 2023 Sep; 30(9):5776-5787. PubMed ID: 37191859 [TBL] [Abstract][Full Text] [Related]
28. High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC. Xu YF; Lu Y; Cheng H; Jiang J; Xu J; Long J; Liu L; Ni Q; Liu C; Yu XJ Curr Mol Med; 2015; 15(4):360-7. PubMed ID: 25829020 [TBL] [Abstract][Full Text] [Related]
30. Abnormal distribution of peripheral lymphocyte subsets induced by PDAC modulates overall survival. Xu YF; Lu Y; Cheng H; Shi S; Xu J; Long J; Liu L; Liu C; Yu X Pancreatology; 2014; 14(4):295-301. PubMed ID: 25062880 [TBL] [Abstract][Full Text] [Related]
31. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection. Wang B; Xu D; Yu X; Ding T; Rao H; Zhan Y; Zheng L; Li L Ann Surg Oncol; 2011 Sep; 18(9):2585-93. PubMed ID: 21347781 [TBL] [Abstract][Full Text] [Related]
32. Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy. Nejati R; Goldstein JB; Halperin DM; Wang H; Hejazi N; Rashid A; Katz MH; Lee JE; Fleming JB; Rodriguez-Canales J; Blando J; Wistuba II; Maitra A; Wolff RA; Varadhachary GR; Wang H Pancreas; 2017 Oct; 46(9):1180-1187. PubMed ID: 28902789 [TBL] [Abstract][Full Text] [Related]
33. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma. Oba A; Ban D; Kirimura S; Akahoshi K; Mitsunori Y; Matsumura S; Ochiai T; Kudo A; Tanaka S; Minoru T J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):480-8. PubMed ID: 27247050 [TBL] [Abstract][Full Text] [Related]
34. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma. Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990 [TBL] [Abstract][Full Text] [Related]
35. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. Qian ZR; Rubinson DA; Nowak JA; Morales-Oyarvide V; Dunne RF; Kozak MM; Welch MW; Brais LK; Da Silva A; Li T; Li W; Masuda A; Yang J; Shi Y; Gu M; Masugi Y; Bui J; Zellers CL; Yuan C; Babic A; Khalaf N; Aguirre A; Ng K; Miksad RA; Bullock AJ; Chang DT; Tseng JF; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Thorner AR; Ducar M; Wollison B; Laing A; Hahn WC; Meyerson M; Fuchs CS; Ogino S; Hornick JL; Hezel AF; Koong AC; Wolpin BM JAMA Oncol; 2018 Mar; 4(3):e173420. PubMed ID: 29098284 [TBL] [Abstract][Full Text] [Related]
36. Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients. Liu F; Li Y; Ren M; Zhang X; Guo X; Lang R; Gu F; Fu L Breast Cancer Res Treat; 2012 Sep; 135(2):459-67. PubMed ID: 22842982 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma. Diana A; Wang LM; D'Costa Z; Allen P; Azad A; Silva MA; Soonawalla Z; Liu S; McKenna WG; Muschel RJ; Fokas E Oncotarget; 2016 Jul; 7(27):40992-41004. PubMed ID: 27329602 [TBL] [Abstract][Full Text] [Related]
38. Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer. Liu C; Cheng H; Luo G; Lu Y; Jin K; Guo M; Ni Q; Yu X Int J Oncol; 2017 Aug; 51(2):686-694. PubMed ID: 28714519 [TBL] [Abstract][Full Text] [Related]
39. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection. Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583 [TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of Ki-67 proliferative index in resectable pancreatic ductal adenocarcinoma. Pergolini I; Crippa S; Pagnanelli M; Belfiori G; Pucci A; Partelli S; Rubini C; Castelli P; Zamboni G; Falconi M BJS Open; 2019 Oct; 3(5):646-655. PubMed ID: 31592095 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]